GLP1R and type 2 diabetes mellitus: Meanwhile, dulaglutide, for example, may exert its metabolic benefits in part through long-term stepwise modulation of gut microbial composition, highlighting a potential bidirectional relationship between GLP-1 receptor agonism and the intestinal microbiome in T2DM treatment.